| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
American Journal of Epidemiology Vol. 127, No. 2: 387-403
Copyright © 1988 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
THE RELATION BETWEEN DEGREE OF BLOOD PRESSURE REDUCTION AND MORTALITY AMONG HYPERTENSIVES IN THE HYPERTENSION DETECTION AND FOLLOW-UP PROGRAM
1The University of Texas Health Science Center at Houston, School of Public Health Houston, TX
2Baylor College of Medicine, USDA/ARS Children's Nutrition Research Center Houston, TX
3Albert Einstein College of Medicine Bronx, NY
4University of Maryland Baltimore, MD
5Hypertension-Nephrology Research, The University of California at Los Angeles Los Angeles, CA
Reprint requests to Coordinating Center for Clinical Trials, HDFP, 1200 Herman Pressler, Suite 801, Houston, TX 77030
The relation between degree of diastolic blood pressure reduction and mortality was examined among hypertensive persons in the Hypertension Detection and Follow-up Program. This program, conducted from 1973–1979, was a muKicenter community-based trial, which followed 10,940 hypertensive participants for five years. The one-year annual visit was the first occasion on which change in blood pressure could be measured on all participants. During the subsequent four years of follow-up on 10,053 participants, 568 deaths occurred. With time-dependent life tables and time-dependent Cox life table regression analyses, the existence of a quadratic function which modeled the relation between diastolic blood pressure reduction and mortality was supported, even after adjusting for other risk factors. The minimum mortality hazard ratio, based on a particular model, occurred at a diastolic blood pressure reduction of 26.2 mmHg (standard error = 13.4). In the whole population and 10.0 mmHg (standard error = 5.3) In the baseline diastolic blood pressure stratum 90–104 mmHg. After this reduction, there was a small increase in the risk of death. There was no evidence of the quadratic function after fitting the same model with systolic blood pressure. Methodological issues involved in studying a particular degree of blood pressure reduction were considered. The confidence interval around the change corresponding to the minimum hazard ratio was wide, and the obtained blood pressure level should not be interpreted as a goal for treatment Blood pressure reduction was attributed not only to pharmacologic therapy but also to regression to the mean, and to other factors unrelated to treatment.
blood pressure; hypertension; mortality
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. S. Goodwin Embracing Complexity: A Consideration of Hypertension in the Very Old J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2003; 58(7): M653 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Boutitie, F. Gueyffier, S. Pocock, R. Fagard, J. P. Boissel, and for the INDANA Project Steering Committee J-Shaped Relationship between Blood Pressure and Mortality in Hypertensive Patients: New Insights from a Meta-Analysis of Individual-Patient Data Ann Intern Med, March 19, 2002; 136(6): 438 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Kaplan What Is Goal Blood Pressure for the Treatment of Hypertension? Arch Intern Med, June 25, 2001; 161(12): 1480 - 1482. [Full Text] [PDF]
|
|
|
|
|
|
G. W. Somes, M. Pahor, R. I. Shorr, W. C. Cushman, and W. B. Applegate The Role of Diastolic Blood Pressure When Treating Isolated Systolic Hypertension Arch Intern Med, September 27, 1999; 159(17): 2004 - 2009. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Flack, J. Neaton, R. Grimm Jr, J. Shih, J. Cutler, K. Ensrud, and S. MacMahon Blood Pressure and Mortality Among Men With Prior Myocardial Infarction Circulation, November 1, 1995; 92(9): 2437 - 2445. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Manttari, L. Tenkanen, V. Manninen, T. Alikoski, and M. H. Frick Antihypertensive Therapy in Dyslipidemic Men : Effects on Coronary Heart Disease Incidence and Total Mortality Hypertension, January 1, 1995; 25(1): 47 - 52. [Abstract] [Full Text]
|
|
|
|
 |
|
 U Lindblad, L Ramstam, L Ryden, J Ranstam, S-O Isacsson, and G Berglund Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project BMJ, March 12, 1994; 308(6930): 681 - 685. [Abstract] [Full Text]
|
|
|
|
|
|
M. H. Weinberger Do No Harm: Antihypertensive Therapy and the J Curve Arch Intern Med, March 1, 1992; 152(3): 473 - 476. [Abstract] [PDF]
|
|
|
|
|
|
L. W. McCloskey, B. M. Psaty, T. D. Koepsell, and G. N. Aagaard Level of Blood Pressure and Risk of Myocardial Infarction Among Treated Hypertensive Patients Arch Intern Med, March 1, 1992; 152(3): 513 - 520. [Abstract] [PDF]
|
|
|
|
|
|
J. H. Warram, L. M. B. Laffel, P. Valsania, A. R. Christlieb, and A. S. Krolewski Excess Mortality Associated With Diuretic Therapy in Diabetes Mellitus Arch Intern Med, July 1, 1991; 151(7): 1350 - 1356. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Farnett, C. D. Mulrow, W. D. Linn, C. R. Lucey, and M. R. Tuley The J-Curve Phenomenon and the Treatment of Hypertension: Is There a Point Beyond Which Pressure Reduction Is Dangerous? JAMA, January 23, 1991; 265(4): 489 - 495. [Abstract] [PDF]
|
|
|
|
|
|
M. H. Alderman, W. L. Ooi, S. Madhavan, and H. Cohen Treatment-Induced Blood Pressure Reduction and the Risk of Myocardial Infarction JAMA, August 18, 1989; 262(7): 920 - 924. [Abstract] [PDF]
|
|